The role of Fas in autoimmune diabetes

被引:453
作者
Chervonsky, AV
Wang, Y
Wong, FS
Visintin, I
Flavell, RA
Janeway, CA
Matis, LA
机构
[1] HOWARD HUGHES MED INST,NEW HAVEN,CT 06510
[2] ALEXION PHARMACEUT,NEW HAVEN,CT 06511
关键词
D O I
10.1016/S0092-8674(00)80178-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunologically privileged sites express Fas ligand (FasL), which protects them from attack by activated T cells that express Fas and die upon contact with FasL. In an attempt to protect nonobese diabetic mice (NOD) from autoimmune diabetes, we made FasL transgenic NOD mice using the beta cell-specific rat insulin-1 promoter. Surprisingly, these transgenic mice showed heightened sensitivity to diabetogenic T cells, which was due to self-destruction of beta cells upon T cell-mediated induction of Fas. Fas-negative NODlpr/lpr animals were resistant to diabetogenic T cells and to spontaneous diabetes. Thus, induction of Fas expression on beta cells and their subsequent destruction constitutes the main pathogenic mechanism in autoimmune diabetes.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 47 条
  • [1] ABERRANT TRANSCRIPTION CAUSED BY THE INSERTION OF AN EARLY TRANSPOSABLE ELEMENT IN AN INTRON OF THE FAS ANTIGEN GENE OF LPR MICE
    ADACHI, M
    WATANABEFUKUNAGA, R
    NAGATA, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1756 - 1760
  • [2] FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    TOUGH, TW
    DAVISSMITH, T
    BRADDY, S
    FALK, B
    SCHOOLEY, KA
    GOODWIN, RG
    SMITH, CA
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 71 - 77
  • [3] DIFFERENCES DEFINED BY BONE-MARROW TRANSPLANTATION SUGGEST THAT LPR AND GLD ARE MUTATIONS OF GENES ENCODING AN INTERACTING PAIR OF MOLECULES
    ALLEN, RD
    MARSHALL, JD
    ROTHS, JB
    SIDMAN, CL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) : 1367 - 1375
  • [4] OVEREXPRESSION OF BETA-2-MICROGLOBULIN IN TRANSGENIC MOUSE ISLET BETA-CELLS RESULTS IN DEFECTIVE INSULIN-SECRETION
    ALLISON, J
    MALCOLM, L
    CULVENOR, J
    BARTHOLOMEUSZ, RK
    HOLMBERG, K
    MILLER, JFAP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) : 2070 - 2074
  • [5] Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
    Andre, I
    Gonzalez, A
    Wang, B
    Katz, J
    Benoist, C
    Mathis, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) : 2260 - 2263
  • [6] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION
    BELLGRAU, D
    GOLD, D
    SELAWRY, H
    MOORE, J
    FRANZUSOFF, A
    DUKE, RC
    [J]. NATURE, 1995, 377 (6550) : 630 - 632
  • [7] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [8] DHEIN J, 1995, NATURE, V375, P78
  • [9] DOMINANT INTERFERING FAS GENE-MUTATIONS IMPAIR APOPTOSIS IN A HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
    FISHER, GH
    ROSENBERG, FJ
    STRAUS, SE
    DALE, JK
    MIDDELTON, LA
    LIN, AY
    STROBER, W
    LENARDO, MJ
    PUCK, JM
    [J]. CELL, 1995, 81 (06) : 935 - 946
  • [10] GILETTEFERGUSON I, 1994, EUR J IMMUNOL, V24, P1181